Single-cell sequencing to elucidate the disparities in the immune microenvironment between PIK3CA mutants and wild types. Sintilimab and anlotinib combination therapy in PD-L1-positive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results